Thymidylate synthetase (EC 2.1.1.45)[1] is the enzyme used to generate thymidine monophosphate (dTMP), which is subsequently phosphorylated to thymidine triphosphate for use in DNA synthesis and repair. By means of reductive methylation, deoxyuridine monophosphate (dUMP) and N5,N10-methylene tetrahydrofolate are together used to form dTMP, yielding dihydrofolate as a secondary product.
As an anti-cancer chemotherapy target, thymidylate synthetase can be inhibited by the thymidylate synthase inhibitors such as fluorinated pyrimidine fluorouracil, or certain folate analogues, including most notably raltitrexed (trade name Tomudex).
See also
References
Further reading
- Carreras CW, and Santi DV (1995). "The Catalytic Mechanism and Structure of Thymidylate Synthase". Annual Review of Biochemistry 64 (1): 721–762. doi:10.1146/annurev.bi.64.070195.003445. PMID 7574499.
- Banerjee D, Mayer-Kuckuk P, Capiaux G, et al. (2002). "Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.". Biochim. Biophys. Acta 1587 (2-3): 164–73. PMID 12084458.
- Liu J, Schmitz JC, Lin X, et al. (2002). "Thymidylate synthase as a translational regulator of cellular gene expression.". Biochim. Biophys. Acta 1587 (2-3): 174–82. PMID 12084459.
- Chu J, Dolnick BJ (2002). "Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA.". Biochim. Biophys. Acta 1587 (2-3): 183–93. PMID 12084460.
- Peters GJ, Backus HH, Freemantle S, et al. (2002). "Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.". Biochim. Biophys. Acta 1587 (2-3): 194–205. PMID 12084461.
- Costi MP, Tondi D, Rinaldi M, et al. (2002). "Structure-based studies on species-specific inhibition of thymidylate synthase.". Biochim. Biophys. Acta 1587 (2-3): 206–14. PMID 12084462.
- Lin D, Li H, Tan W, et al. (2007). "Genetic polymorphisms in folate- metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development.". Forum of nutrition 60: 140–5. doi:10.1159/0000107090 (inactive 2008-10-14). PMID 17684410.
|
PDB Gallery |
|
|
|
|
1hvy: Human thymidylate synthase complexed with dUMP and Raltitrexed, an antifolate drug, is in the closed conformation
|
|
|
|
1hw3: STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS
|
|
|
|
1hw4: STRUCTURE OF THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS
|
|
|
|
1hzw: CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE
|
|
|
|
1i00: CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE, TERNARY COMPLEX WITH DUMP AND TOMUDEX
|
|
|
|
1ju6: Human Thymidylate Synthase Complex with dUMP and LY231514, A Pyrrolo(2,3-d)pyrimidine-based Antifolate
|
|
|
|
1juj: Human Thymidylate Synthase Bound to dUMP and LY231514, a Pyrrolo(2,3-d)pyrimidine-based Antifolate
|
|
|
|
1ypv: Structure of human thymidylate synthase at low salt conditions
|
|
|
|
2onb: Human Thymidylate Synthase at low salt conditions with PDPA bound
|
|
|
|
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)